Back

Evaluation of vascular cell adhesion molecule-1 (VCAM-1) level changes in patients with lymphoproliferative diseases during antitumor therapy

20 May 2025 (10:27 - 10:36)
Organised by: Logo
Congress Presentation Part of: Emerging insights in cardio-oncology: biomarkers, cardiotoxicity, and protective therapies Cardio-Oncology HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Rano Alieva

Republican Specialized Scientific Practical Medical Center Of Cardiology, Tashkent (Uzbekistan)

6 More presentations in this session

Presentation thumbnail
Sacubitril-valsartan reduced H-FABP, hs-cTnT, hs-CRP and monocyte-to-lymphocyte ratio in anthracycline-treated preclinical models through NLRP3-mTOR-AKT pathways
Doctor N. Maurea (Naples, IT)
Abstract Slides Video
Presentation thumbnail
Heart failure hospitalization and outcomes in cancer patients undergoing immune checkpoint inhibitor treatment: a systematic review and meta-analysis
Doctor N. Sari (Jakarta, ID)
Abstract Slides Video
Presentation thumbnail
The predictive value of baseline troponin measurements in patients treated with immune checkpoint inhibitors
Doctor M. Laufer-Perl (Tel Aviv, IL)
Abstract Slides Video
Presentation thumbnail
GLP1-RA associated with SGLT2i as new therapy of anthracycline-induced cardiotoxicity under hyperglycemia: biochemical and preclinical evidences
Doctor N. Maurea (Naples, IT)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in cancer patients with diabetes mellitus
Doctor M. Gvili Perelman (Tel Aviv, IL)
Abstract Slides Video

Access the full session

Session thumbnail
Emerging insights in cardio-oncology: biomarkers, cardiotoxicity, and protective therapies
Video

The Event

Event poster

Heart Failure 2025

20 May 2025 10:27 CET
You may be interested in
thumbnail
Congress Presentation
Proinflammatory status, vascular wall morphofunctional state and relative associations in patients with lymphomas before chemotherapy
thumbnail
Congress Session
Anticipating risk to protect the heart during cancer treatment
thumbnail
Congress Session
Daily cardiac problems in cancer patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources